Cellular Biomedicine raises $14.5M

Cell therapy company Cellular Biomedicine Group Inc. (NASDAQ:CBMG) said on Dec. 28, 2017, it raised $14.5 million through the sale of 1.2 million shares at $12 across two private placements. Investors included Maplebrook, Windsor Capital, interim CEO Bizuo (Tony) Liu, CSO Yihong Yao, and Andrew Chan, who is SVP of legal, corporate development and board security...